We’ve recently been looking back at the journey we’ve been on with psiXchange and wanted to explore one of our latest features which has been added after listening to our growing customer base and is set to change how sites interact with and access your critical data.

Amidst changes to the many laws altered by Brexit is uncertainty over the pharmacovigilance market. With time passing and the likelihood of a full withdrawal increasing, what shape will the medical and pharmacovigilance industry take with the UK leaving the European Union?

Increasing pressure is being placed on pharmacovigilance across the globe. While it is known for its rapid pace of advancement in best practice and technology, more is now being demanded in terms of the scope of traditional roles for employed staff and contractors.

Companies in the Life Sciences domain, regardless of whether they do business on a global or regional scale, continuously face many reporting obligations, a very prominent example being reporting on adverse drug reactions or adverse events (SUSARs).